Related Blog Posts
Additional therapy and screening may be needed for patients with mucinous breast cancer (News-Medical-Net)
23 hours ago ago from Cure Breast Cancer Blog
In a large review of breast cancer patients with mucinous carcinoma, researchers at The University of Texas M. D. Anderson Cancer Center have identified an association between this rare type of breast cancer long-associated with a favorable prognosis and multiple tumors undetected by mammography or ultrasound. Excerpt from: Additional therapy and screening may be needed for patients with mucinous breast cancer (News-Medical-Net)
Related contentDC-SCRIPT found to have prognostic value in breast cancer | Science Codex
9 hours ago ago from Science Codex | Science news, science articles, all day, every day
RSS Feeds ยป Sitewide | Earth | Heavens | Body | Brain | Culture | Technology Home Earth Heavens Body Brain Culture Tech DC-SCRIPT found to have prognostic value in breast cancer Posted On: December 14, 2009 - 9:30pm DC-SCRIPT, or dendritic cell-specific transcript, is a key regulator of nuclear receptor activity that may ...
Related contentAnti-Estrogens May Offer Protection Against Lung Cancer Mortality - BeWell Buddy
17 hours ago ago from BeWell Buddy » Your online buddy for staying healthy, wealthy, and wise
Anti-estrogens as therapy for breast cancer may also reduce the risk of death from lung cancer, according to study results presented at the CTRC-AACR San Antonio Breast Cancer Symposium, held here Dec. 9-13, 2009. We found a reduction in lung cancer mortality among women treated with anti-estrogens for breast cancer
Related contentRole Of Bevacizumab In Metastatic Breast Cancer
8 hours ago ago from Cancerwise | Cancer blog from M. D. Anderson Cancer Center
By Gary Whitman, Professor, Diagnostic Radiology Two reports at the CTRC- AACR San Antonio Breast Cancer Symposium highlighted the role of bevacizumab in the treatment of metastatic and/or locally recurrent breast cancer . Bevacizumab is an angiogenesis inhibitor , a therapy designed to inhibit the formation of new blood vessels. The rationale for the use of angiogenesis inhibitors like bevacizumab is based on the understanding that ...
Related contentChemo With Herceptin May Be Best for Some Breast Cancers
20 hours ago ago from Medical News
Chemo With Herceptin May Be Best for Some Breast Cancers New research suggests that certain breast cancer patients who take the drug Herceptin during chemotherapy, instead of taking it afterward, fare better, leading one of the study authors to say patients should routinely take the drug with chemo.The patients at issue are those with HER2-positive breast cancer, which accounts for 20 percent to 25 percent of all cases of the ...
Related contentRelated News
Promising new developments on the breast cancer front
8 hours ago ago from DailyFinance
The San Antonio Breast Cancer Symposium , held Dec. 9-13, brought mostly good news for breast cancer patients and drugmakers. And that's a welcome development: Aside from non-melanoma skin cancer, breast cancer is the most common form of cancer in women and the second-leading cause of cancer death in women. Estimates for 2009 put the number of new cases at over 192,000 women and nearly 2,000 men, with over 40,000 deaths in women and 440 in ...
Related contentCheckup: Medical journal faults reporting on health issues
2 hours ago ago from Washington Post - Health
Adapted from The Post's daily health blog. Rx: Take health news with a grain of salt It would be nice to think that you could trust journalists to deliver the straight scoop when it comes to covering health news. But sometimes we don't. Journalists' getting health stories wrong is the subject of an editorial published online Nov. 20 in the Journal of the National Cancer Institute. It notes two examples of major health stories gone awry. ...
Related contentDiane Balma: A Battle Close To Home: Thirty Eight Years After Nixon's Declaration Of War
9 hours ago ago from Huffington Post
Last week's release of the "Annual Report to the Nation on the Status of Cancer" is cause for hope and ultimately, a call to action. For the second consecutive year, the report found a statistically significant but modest decline in the incidence (0.7%) and death rates (1.5%) from all cancers combined for both women and men. On closer examination, the story gets more complex. While colorectal cancer saw sharp overall drops in deaths and ...
Related contentRelated Videos
